Also, presumably NCR-ILC3s are pro-tumoral by secreting IL-17 in hepatocarcinoma and lung cancer whereas the IL-22 produced by these NCR-ILC3s promotes tumor growth and metastasis in breast and pancreas. This evidence concerns the gene IL17A and lung carcinoma.